What do patients want? Patient preferences and surrogate decision making in the treatment of colorectal cancer

Diseases of the Colon and Rectum

Volumn 46, Issue 10, 2003, Pages 1351-1357

  Solomon, Michael J ^a   Pager, Chet K ^a   Keshava, Anil ^a   Findlay, Michael ^a   Butow, Phyllis ^a   Salkeld, Glenn P ^a   Roberts, Rachael ^a  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

Colorectal cancer; Outcomes; Preferences; Quality of life

Indexed keywords

ANTINEOPLASTIC AGENT;

ARTICLE; AUSTRALIA; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; COLORECTAL CANCER; COLOSTOMY; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MEDICAL DECISION MAKING; MEDICAL SPECIALIST; NORMAL HUMAN; ONCOLOGY; POSTOPERATIVE PERIOD; QUALITY OF LIFE; QUESTIONNAIRE; SURGEON; TREATMENT PLANNING;

ATTITUDE OF HEALTH PERSONNEL; ATTITUDE TO HEALTH; AUSTRALIA; COLORECTAL NEOPLASMS; COLORECTAL SURGERY; COLOSTOMY; DATA COLLECTION; DECISION MAKING; HUMANS; MEDICAL ONCOLOGY; PATIENT PARTICIPATION; PATIENT SATISFACTION; QUALITY OF LIFE; SURVIVAL;

EID: 0142011611     PISSN: 00123706     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10350-004-6749-0     Document Type: Article

References (25)

1. MacKillop WJ, Ward GK, O'Sullivan B. The use of expert surrogates to evaluate clinical trials in non-small cell lung cancer. Br J Cancer 1986;54:661-7.
2. Moore MJ, O'Sullivan B, Tannock IF. How expert physicians would wish to be treated if they had genitourinary cancer. J Clin Oncol 1988;6:1736-45.
3. Solomon MJ, Laxamana A, Devore L, McLeod RS. Randomized controlled trials in surgery. Surgery 1994;115:707-12.
4. Taylor KM, Margolese RG, Soskolne CL. Physicians' reasons for not entering eligible patients in a randomized control trial of surgery for breast cancer. N Engl J Med 1984;310:1363-7.
5. Solomon MJ, Mcleod RS. Should we be performing more randomized controlled trials evaluating surgical operations? Surgery 1995;118:459-67.
6. Gattellari M, Ward JE, Solomon MJ. Randomized, controlled trials in surgery: perceived barriers and attitudes of Australian colorectal surgeons. Dis Colon Rectum 2001;44:1413-20.
7. Till JE, Sutherland HJ, Meslin EM. Is there a role for preference assessments in research on quality of life in oncology? Qual Life Res 1992;1:31-40.
8. Fagerlin A, Ditto PH, Danks JH, Houts RM, Smucker WD. Projection in surrogate decisions about life-sustaining medical treatments. Health Psychol 2001;20:166-75.
9. Covinsky KE, Fuller JD, Yaffe K, et al. Communication and decision-making in seriously ill patients: findings of the SUPPORT project. The Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments. J Am Geriatr Soc 2000;48(Suppl 5):S187-93.
10. Kennelly C, Bowling A. Suffering in deference: a focus group study of older cardiac patients' preferences for treatment and perceptions of risk. Qual Health Care 2001;10(Suppl 1):i23-8.
11. Robinson A, Thomson R. Variability in patient preferences for participating in medical decision making: implication for the use of decision support tools. Qual Health Care 2001;10(Suppl 1):i34-8.
12. NHMRC guidelines for the prevention, early detection and management of colorectal cancer (CRC). Canberra: Commonwealth of Australia; 1999.
13. Llewellyn-Thomas HA, Naylor DC, Cohen MM, Basinski AS, Ferris LE, Williams JI. Studying patients preferences in health care decision making. Health Services Research Group. Can Med Assoc J 1992;147:859-64.
14. Palda VA, Llewellyn-Thomas HA, Mackenzie RG, Pritchard KI, Naylor CD. Breast cancer patients' attitudes about rationing postlumpectomy radiation therapy: applicability of trade-off methods to policy-making. J Clin Oncol 1997;15:3192-200.
15. Llewellyn-Thomas HA, Sutherland HJ, Ciampi A, Etezadi-Amoli J, Boyd NF, Till JE. The assessment of values in laryngeal cancer: reliability of measurement methods. J Chronic Dis 1984;37:283-91.
16. O'Connor AM, Boyd NF, Warde P, Stolbach L, Till JE. Eliciting preferences for alternative drug therapies in oncology: influence of treatment outcome description, elicitation technique and treatment experience on preferences. J Chronic Dis 1987;40:811-8.
17. Llewellyn-Thomas HA. Patients health care decision making: a framework for descriptive and experimental investigations. Med Decis Making 1995;15:101-6.
18. O'Connor AM. Validation of a decisional conflict scale. Med Decis Making 1995;15:25-30.
19. Llewellyn-Thomas HA, McGreal MJ, Thiel EC. Cancer patients' decision making and trial entry preferences: the effects of "framing" information about short-term toxicity and long-term survival. Med Decis Making 1995;15:4-12.
20. Jansen SJ, Kievit J, Nooij MA, Stiggelbout AM. Stability of patients' preferences for chemotherapy: the impact of experience. Med Decis Making 2001;21:295-306.
21. Llewellyn-Thomas HA, Sutherland HJ, Thiel EC. Do patients' evaluations of a future health state change when they actually enter that state? Med Care 1993;31:1002-12.
22. Tsevat J, Goldman L, Soukup JR, et al. Stability of time-tradeoff utilities in survivors of myocardial infarction. Med Decis Making 1993;13:161-5.
23. Miller AR, Cantor SB, Peoples GE, Pearlstone DB, Skibber JM. Quality of life and cost effectiveness analysis of therapy for locally recurrent rectal cancer. Dis Colon Rectum 2000;43:1695-703.
24. Stiggelbout AM, de Haas CJ. Patient preference for cancer therapy: an overview of measurement approaches. J Clin Oncol 2001;19:220-30.
25. Tsevat J, Dawson NV, Wu AW, et al. Health values of hospitalized patients 80 years of older. HELP Investigators. Hospitalized Elderly Longitudinal Project. JAMA 1998;279:371-5.